The cytoplasmic AID complex

Seminars in Immunology

Volumn 24, Issue 4, 2012, Pages 273-280

  Häsler, Julien ^a   Rada, Cristina ^a   Neuberger, Michael S ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Activation induced deaminase; AID; Antibody diversification; Chaperone; Cytoplasmic complex; EEF1A; Nuclear:cytoplasmic traffic; Translation elongation factor 1

Indexed keywords

CYTOPLASM PROTEIN; ELONGATION FACTOR 1ALPHA; HEAT SHOCK PROTEIN 90; MESSENGER RNA; PROTEIN AID; UNCLASSIFIED DRUG;

HUMAN; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; REVIEW;

ANIMALS; CYTIDINE DEAMINASE; CYTOPLASM; HUMANS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RNA;

EID: 84865167294     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.05.004     Document Type: Review

References (86)

1. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annual Review of Biochemistry 2007, 76:1-22.
2. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., et al. The biochemistry of somatic hypermutation. Annual Review of Immunology 2008, 26:481-511.
3. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annual Review of Immunology 2008, 26:261-292.
4. de Yebenes V.G., Belver L., Pisano D.G., Gonzalez S., Villasante A., Croce C., et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. Journal of Experimental Medicine 2008, 205(10):2199-2206.
5. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28(5):630-638.
6. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28(5):621-629.
7. Aoufouchi S., Faili A., Zober C., D'Orlando O., Weller S., Weill J.C., et al. Proteasomal degradation restricts the nuclear lifespan of AID. Journal of Experimental Medicine 2008, 205(6):1357-1368.
8. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., et al. AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 2005, 438(7067):508-511.
9. Pasqualucci L., Kitaura Y., Gu H., Dalla-Favera.R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(2):395-400.
10. Brar S.S., Watson M., Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. Journal of Biological Chemistry 2004, 279(25):26395-26401.
11. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(7):1975-1980.
12. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P., Nussenzweig M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. Journal of Experimental Medicine 2004, 199(9):1235-1244.
13. Uchimura Y., Barton L.F., Rada C., Neuberger M.S. REG-gamma associates with and modulates the abundance of nuclear activation-induced deaminase. Journal of Experimental Medicine 2011, 208(12):2385-2391.
14. Geisberger R., Rada C., Neuberger M.S. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(16):6736-6741.
15. Patenaude A.M., Di Noia J.M. The mechanisms regulating the subcellular localization of AID. Nucleus 2010, 1(4):325-331.
16. Patenaude A.M., Orthwein A., Hu Y., Campo V.A., Kavli B., Buschiazzo A., et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nature Structural & Molecular Biology 2009, 16(5):517-527.
17. Cattoretti G., Buttner M., Shaknovich R., Kremmer E., Alobeid B., Niedobitek G. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006, 107(10):3967-3975.
18. Engels K., Jungnickel B., Tobollik S., Hansmann M.L., Kriener S., Willenbrock K. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow. Applied Immunohistochemistry and Molecular Morphology 2008, 16(6):521-529.
19. Greiner A., Tobollik S., Buettner M., Jungnickel B., Herrmann K., Kremmer E., et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. Journal of Pathology 2005, 205(5):541-547.
20. Ordinario E.C., Yabuki M., Larson R.P., Maizels N. Temporal regulation of Ig gene diversification revealed by single-cell imaging. Journal of Immunology 2009, 183(7):4545-4553.
21. Rada C., Jarvis J.M., Milstein C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(10):7003-7008.
22. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003, 422(6933):726-730.
23. Okazaki I.M., Okawa K., Kobayashi M., Yoshikawa K., Kawamoto S., Nagaoka H., et al. Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(19):7920-7925.
24. Hasler J., Rada C., Neuberger M.S. Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1alpha (eEF1A). Proceedings of the National Academy of Sciences of the United States of America 2011, 108(45):18366-18371.
25. Walter P., Blobel G. Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 1980, 77(12):7112-7116.
26. Wild K., Weichenrieder O., Strub K., Sinning I., Cusack S. Towards the structure of the mammalian signal recognition particle. Current Opinion in Structural Biology 2002, 12(1):72-81.
27. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435(7038):108-114.
28. Soros V.B., Yonemoto W., Greene W.C. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathogens 2007, 3(2):e15.
29. Wedekind J.E., Gillilan R., Janda A., Krucinska J., Salter J.D., Bennett R.P., et al. Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits. Journal of Biological Chemistry 2006, 281(50):38122-38126.
30. Tan L., Sarkis P.T., Wang T., Tian C., Yu X.F. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB Journal 2009, 23(1):279-287.
31. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C., et al. Cellular APOBEC3G restricts HIV-1 infection in resting CD4(+) T cells. Nature 2010, 466(7303):276.
32. Xie K., Sowden M.P., Dance G.S., Torelli A.T., Smith H.C., Wedekind J.E. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(21):8114-8119.
33. Wang J., Shinkura R., Muramatsu M., Nagaoka H., Kinoshita K., Honjo T. Identification of a specific domain required for dimerization of activation-induced cytidine deaminase. Journal of Biological Chemistry 2006, 281(28):19115-19123.
34. Wang J., Shinkura R., Muramatsu M., Nagaoka H., Kinoshita K., Honjo T. Identification of a specific domain required for dimerization of activation-induced cytidine deaminase. Journal of Biological Chemistry 2008, 283(1):660.
35. Brar S.S., Sacho E.J., Tessmer I., Croteau D.L., Erie D.A., Diaz M. Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA. DNA Repair (Amst) 2008, 7(1):77-87.
36. Bhagwat A.S., Carpenter M.A., Bujnicki J.M. Is AID a monomer in solution?. DNA Repair (Amst) 2008, 7(3):349-350. author reply 51-2.
37. Pham P., Bransteitter R., Petruska J., Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003, 424(6944):103-107.
38. Dickerson S.K., Market E., Besmer E., Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. Journal of Experimental Medicine 2003, 197(10):1291-1296.
39. Nonaka T., Doi T., Toyoshima T., Muramatsu M., Honjo T., Kinoshita K. Carboxy-terminal domain of AID required for its mRNA complex formation in vivo. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(8):2747-2751.
40. Ule J., Jensen K., Mele A., Darnell R.B. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods 2005, 37(4):376-386.
41. Metzner M., Schuh W., Roth E., Jack H.M., Wabl M. Two forms of activation-induced cytidine deaminase differing in their ability to bind agarose. PLoS One 2010, 5(1):e8883.
42. Chaudhuri J., Khuong C., Alt F.W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 2004, 430(7003):992-998.
43. Schoetz U., Cervelli M., Wang Y.D., Fiedler P., Buerstedde J.M. E2A expression stimulates Ig hypermutation. Journal of Immunology 2006, 177(1):395-400.
44. Pavri R., Gazumyan A., Jankovic M., Di Virgilio M., Klein I., Ansarah-Sobrinho C., et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010, 143(1):122-133.
45. Xu Z., Fulop Z., Wu G., Pone E.J., Zhang J., Mai T., et al. 14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination. Nature Structural & Molecular Biology 2010, 17(9):1124-1135.
46. Conticello S.G., Ganesh K., Xue K., Lu M., Rada C., Neuberger M.S. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Molecular Cell 2008, 31(4):474-484.
47. Nowak U., Matthews A.J., Zheng S., Chaudhuri J. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nature Immunology 2011, 12(2):160-166.
48. Jeevan-Raj B.P., Robert I., Heyer V., Page A., Wang J.H., Cammas F., et al. Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. Journal of Experimental Medicine 2011.
49. Demorest Z.L., MacDuff D.A., Brown W.L., Morham S.G., Parise L.V., Harris R.S. The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination. PLoS One 2010, 5(7):e11660.
50. Maeda K., Singh S.K., Eda K., Kitabatake M., Pham P., Goodman M.F., et al. GANP-mediated recruitment of activation-induced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. Journal of Biological Chemistry 2010, 285(31):23945-23953.
51. Zaprazna K., Atchison M.L. YY1 controls immunoglobulin class switch recombination and nuclear AID levels. Molecular and Cellular Biology 2012, MCB 05989-11 [published ahead of print January 30, 2012].
52. Orthwein A., Patenaude A.M., Affar el B., Lamarre A., Young J.C., Di Noia J.M. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. Journal of Experimental Medicine 2010, 207(12):2751-2765.
53. Orthwein A., Zahn A., Methot S.P., Godin D., Conticello S.G., Terada K., et al. Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1. EMBO Journal 2011, 10.1038/emboj.2011.417.
54. Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Bioscience, Biotechnology, and Biochemistry 2002, 66(1):1-21.
55. Lamberti A., Caraglia M., Longo O., Marra M., Abbruzzese A., Arcari P. The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids 2004, 26(4):443-448.
56. Mateyak M.K., Kinzy T.G. eEF1A: thinking outside the ribosome. Journal of Biological Chemistry 2010, 285(28):21209-21213.
57. Gross S.R., Kinzy T.G. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nature Structural & Molecular Biology 2005, 12(9):772-778.
58. Pittman Y.R., Kandl K., Lewis M., Valente L., Kinzy T.G. Coordination of eukaryotic translation elongation factor 1A (eEF1A) function in actin organization and translation elongation by the guanine nucleotide exchange factor eEF1Balpha. Journal of Biological Chemistry 2009, 284(7):4739-4747.
59. Chuang S.M., Chen L., Lambertson D., Anand M., Kinzy T.G., Madura K. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Molecular and Cellular Biology 2005, 25(1):403-413.
60. Hotokezaka Y., Tobben U., Hotokezaka H., Van Leyen K., Beatrix B., Smith D.H., et al. Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides. Journal of Biological Chemistry 2002, 277(21):18545-18551.
61. Bunai F., Ando K., Ueno H., Numata O. Tetrahymena eukaryotic translation elongation factor 1A (eEF1A) bundles filamentous actin through dimer formation. Journal of Biochemistry 2006, 140(3):393-399.
62. Morita K., Bunai F., Numata O. Roles of three domains of tetrahymena eEF1A in bundling F-actin. Zoological Science 2008, 25(1):22-29.
63. Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(7):2199-2204.
64. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131(6):1190-1203.
65. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nature Biotechnology 2005, 23(1):94-101.
66. Chang Y.W., Traugh J.A. Phosphorylation of elongation factor 1 and ribosomal protein S6 by multipotential S6 kinase and insulin stimulation of translational elongation. Journal of Biological Chemistry 1997, 272(45):28252-28257.
67. Chang Y.W., Traugh J.A. Insulin stimulation of phosphorylation of elongation factor 1 (eEF-1) enhances elongation activity. European Journal of Biochemistry 1998, 251(1-2):201-207.
68. Lin K.W., Yakymovych I., Jia M., Yakymovych M., Souchelnytskyi S. Phosphorylation of eEF1A1 at Ser300 by TbetaR-I results in inhibition of mRNA translation. Current Biology 2010, 20(18):1615-1625.
69. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325(5942):834-840.
70. Dever T.E., Costello C.E., Owens C.L., Rosenberry T.L., Merrick W.C. Location of seven post-translational modifications in rabbit elongation factor 1 alpha including dimethyllysine, trimethyllysine, and glycerylphosphorylethanolamine. Journal of Biological Chemistry 1989, 264(34):20518-20525.
71. Rosenberry T.L., Krall J.A., Dever T.E., Haas R., Louvard D., Merrick W.C. Biosynthetic incorporation of [3H]ethanolamine into protein synthesis elongation factor 1 alpha reveals a new post-translational protein modification. Journal of Biological Chemistry 1989, 264(13):7096-7099.
72. Whiteheart S.W., Shenbagamurthi P., Chen L., Cotter R.J., Hart G.W. Murine elongation factor 1 alpha (EF-1 alpha) is posttranslationally modified by novel amide-linked ethanolamine-phosphoglycerol moieties. Addition of ethanolamine-phosphoglycerol to specific glutamic acid residues on EF-1 alpha. Journal of Biological Chemistry 1989, 264(24):14334-14341.
73. Greganova E., Heller M., Butikofer P. A structural domain mediates attachment of ethanolamine phosphoglycerol to eukaryotic elongation factor 1A in trypanosoma brucei. PLoS One 2010, 5(3):e9486.
74. Gourzi P., Leonova T., Papavasiliou F.N. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 2006, 24(6):779-786.
75. Gourzi P., Leonova T., Papavasiliou F.N. Viral induction of AID is independent of the interferon and the toll-like receptor signaling pathways but requires NF-kappaB. Journal of Experimental Medicine 2007, 204(2):259-265.
76. Nussenzweig A., Nussenzweig M.C. Origin of chromosomal translocations in lymphoid cancer. Cell 2010, 141(1):27-38.
77. Kjaer S., Wind T., Ravn P., Ostergaard M., Clark B.F., Nissim A. Generation and epitope mapping of high-affinity scFv to eukaryotic elongation factor 1A by dual application of phage display. European Journal of Biochemistry 2001, 268(12):3407-3415.
78. Bohnsack M.T., Regener K., Schwappach B., Saffrich R., Paraskeva E., Hartmann E., et al. Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm. EMBO Journal 2002, 21(22):6205-6215.
79. Calado A., Treichel N., Muller E.C., Otto A., Kutay U. Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA. EMBO Journal 2002, 21(22):6216-6224.
80. Wu X., Geraldes P., Platt J.L., Cascalho M. The double-edged sword of activation-induced cytidine deaminase. Journal of Immunology 2005, 174(2):934-941.
81. Edmonds B.T., Murray J., Condeelis J. pH regulation of the F-actin binding properties of Dictyostelium elongation factor 1 alpha. Journal of Biological Chemistry 1995, 270(25):15222-15230.
82. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., et al. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(23):8798-8803.
83. Barreto V.M., Pan-Hammarstrom Q., Zhao Y., Hammarstrom L., Misulovin Z., Nussenzweig M.C. AID from bony fish catalyzes class switch recombination. Journal of Experimental Medicine 2005, 202(6):733-738.
84. Wakae K., Magor B.G., Saunders H., Nagaoka H., Kawamura A., Kinoshita K., et al. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID. International Immunology 2006, 18(1):41-47.
85. Yamane A., Resch W., Kuo N., Kuchen S., Li Z., Sun H.W., et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nature Immunology 2011, 12(1):62-69.
86. Wang M., Yang Z., Rada C., Neuberger M.S. AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity. Nature Structural & Molecular Biology 2009, 16(7):769-776.